Recruiting Autism Studies in Dothan
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (AS...
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to ...
About Autism Clinical Trials in Dothan
Autism spectrum disorder (ASD) is a developmental condition affecting communication, behavior, and social interaction. The spectrum ranges widely in severity and presentation. Support includes behavioral therapy, speech therapy, social skills training, and medications for specific symptoms.
There are currently 2 autism clinical trials recruiting participants in Dothan, ALABAMA. These studies are seeking a combined 324 participants. Research is being sponsored by Intra-Cellular Therapies, Inc., MapLight Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Autism Clinical Trials in Dothan — FAQ
Are there autism clinical trials in Dothan?
Yes, there are 2 autism clinical trials currently recruiting in Dothan, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Dothan?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dothan research site will contact you about next steps.
Are clinical trials in Dothan free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dothan studies also compensate for your time and travel.
What autism treatments are being tested?
The 2 active trials in Dothan are testing new therapies including novel drugs, biologics, and treatment approaches for autism.
Data updated March 2, 2026 from ClinicalTrials.gov